Limited awareness and use of HIV post-exposure prophylaxis among people vulnerable to HIV acquisition in Western Kenya: a cross-sectional analysis
- PMID: 40569897
- PMCID: PMC12231640
- DOI: 10.1002/jia2.26472
Limited awareness and use of HIV post-exposure prophylaxis among people vulnerable to HIV acquisition in Western Kenya: a cross-sectional analysis
Abstract
Introduction: HIV post-exposure prophylaxis (PEP) can prevent HIV acquisition and facilitates linkage to pre-exposure prophylaxis (PrEP) for people with ongoing vulnerability. We assessed PEP awareness and use in Western Kenya.
Methods: We used cross-sectional screening/enrolment data from the Multinational Observational Cohort of HIV and other Infections (MOCHI) study. Eligible participants had behavioural vulnerability to HIV and were ages 14-55 years. Participants completed questionnaires on demographics, sexual/behavioural history, and PEP/PrEP awareness and use. Depression was assessed using the Patient Health Questionnaire (PHQ-9) with none/minimal, mild and moderate/severe depression defined as PHQ-9 scores of 0-4, 5-9 and ≥10, respectively. We used multivariable robust Poisson regression with purposeful variable selection to estimate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) for factors associated with PEP awareness.
Results: From December 2021 to May 2023, 398 participants indicated whether they heard of PEP. The median age was 22 years (IQR 19-24), 316/399 (79.2%) were female and 315/389 (81.0%) reported sex work or transactional sex. One hundred fourteen (28.6%) participants had never heard of PEP, of whom 79 (69.3%) had also not heard of PrEP. Among 284 participants who had heard of PEP, 74 (26.1%) did not know where to access it. Seventy-one participants (17.8%) had taken PEP, of whom 17 (23.9%) encountered problems accessing PEP such as unavailability (n = 5) or prohibitive expense (n = 4). In the final model, only <12 years of education (aPR 1.65 [95% CI 1.16-2.34]) and not cohabitating (aPR 2.81 [95% CI = 1.11-7.08]) were associated with never having heard of PEP. Among participants who had heard of PEP, factors associated with not knowing where to access PEP were <12 years of education (aPR 2.20 [95% CI 1.37-3.54]) and depression (mild aPR 1.86 [95% CI 1.17-2.96]; moderate/severe aPR 1.84 [95% CI 1.09-3.09], compared to none/minimal).
Conclusions: Despite enrolling a behaviourally vulnerable group potentially eligible for PEP, we identified substantial gaps in PEP awareness, access and use. Demand generation and improved access to PEP are needed to maximize the impact on reducing HIV incidence. Interventions to improve PEP awareness and access may be most impactful for people with lower education or when coupled with mental health services.
Keywords: HIV; health risk behaviours; implementation science; post‐exposure prophylaxis; pre‐exposure prophylaxis; sexually transmitted infection.
© 2025 Henry M. Jackson Foundation for the Advancement of Military Medicine. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
Similar articles
-
Inequities in HIV prevention among trans and/or non-binary people: a cross-sectional survey analysis of PrEP and PEP awareness and use in Spain.Int J Equity Health. 2025 Jul 7;24(1):197. doi: 10.1186/s12939-025-02574-4. Int J Equity Health. 2025. PMID: 40624632 Free PMC article.
-
Awareness, access to and uptake of HIV prevention interventions among youth in Zimbabwe: a population-based survey.BMC Infect Dis. 2025 May 16;25(1):709. doi: 10.1186/s12879-025-11076-1. BMC Infect Dis. 2025. PMID: 40380099 Free PMC article. Clinical Trial.
-
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646068
-
Factors associated with PEP awareness among adolescent girls and young women in Eswatini.J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26486. doi: 10.1002/jia2.26486. J Int AIDS Soc. 2025. PMID: 40569858 Free PMC article.
-
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002835. doi: 10.1002/14651858.CD002835.pub3. Cochrane Database Syst Rev. 2007. PMID: 17253483 Free PMC article.
Cited by
-
HIV Post Exposure Prophylaxis: prospects, opportunities and challenges.J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26511. doi: 10.1002/jia2.26511. J Int AIDS Soc. 2025. PMID: 40569861 Free PMC article. No abstract available.
References
-
- Public health service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. Can Dis Wkly Rep. 1990;16 Suppl 2:4–13. - PubMed
-
- 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1998;47(Rr‐1):1–111. - PubMed
-
- World Health Organization & International Labour Organization . Post‐exposure prophylaxis to prevent HIV infection: Joint WHO/ILO guidelines on post exposure prophylaxis (PEP) to prevent HIV infection; 2007. Available from: https://apps.who.int/iris/handle/10665/43838. Accessed 4 January 2023.
-
- Smith DK, Grohskopf LA, Black RJ, Auerbach JD, Veronese F, Struble KA, et al. Antiretroviral postexposure prophylaxis after sexual, injection‐drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2005;54(Rr‐2):1–20. - PubMed
-
- Announcement: updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection‐drug use, or other nonoccupational exposure to HIV—United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(17):458. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous